NO20083315L - 3,5-substituert piperidin-bestanddeler som renin-inhibitorer - Google Patents
3,5-substituert piperidin-bestanddeler som renin-inhibitorerInfo
- Publication number
- NO20083315L NO20083315L NO20083315A NO20083315A NO20083315L NO 20083315 L NO20083315 L NO 20083315L NO 20083315 A NO20083315 A NO 20083315A NO 20083315 A NO20083315 A NO 20083315A NO 20083315 L NO20083315 L NO 20083315L
- Authority
- NO
- Norway
- Prior art keywords
- substituted piperidine
- treatment
- compound
- renin
- constituents
- Prior art date
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title abstract 4
- 150000003053 piperidines Chemical class 0.000 title abstract 2
- 239000000470 constituent Substances 0.000 title 1
- 239000002461 renin inhibitor Substances 0.000 title 1
- 229940086526 renin-inhibitors Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 102100028255 Renin Human genes 0.000 abstract 3
- 108090000783 Renin Proteins 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 3
- -1 piperidine compound Chemical class 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05028771 | 2005-12-30 | ||
| GB0604223A GB0604223D0 (en) | 2006-03-02 | 2006-03-02 | Organic compounds |
| GB0611390A GB0611390D0 (en) | 2006-06-08 | 2006-06-08 | Organic compounds |
| PCT/EP2006/012581 WO2007077005A1 (en) | 2005-12-30 | 2006-12-28 | 3 , 5-substitγued piperidine compounds as renin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20083315L true NO20083315L (no) | 2008-09-19 |
Family
ID=37875514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20083315A NO20083315L (no) | 2005-12-30 | 2008-07-25 | 3,5-substituert piperidin-bestanddeler som renin-inhibitorer |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8129411B2 (es) |
| EP (2) | EP2420491B1 (es) |
| JP (1) | JP5306821B2 (es) |
| KR (1) | KR20080086921A (es) |
| AR (1) | AR058885A1 (es) |
| AU (1) | AU2006332124B2 (es) |
| BR (1) | BRPI0620736A2 (es) |
| CA (1) | CA2633624C (es) |
| CR (1) | CR10091A (es) |
| EC (1) | ECSP088587A (es) |
| ES (2) | ES2430139T3 (es) |
| IL (1) | IL192024A0 (es) |
| MA (1) | MA30073B1 (es) |
| NO (1) | NO20083315L (es) |
| NZ (1) | NZ569135A (es) |
| PE (2) | PE20071177A1 (es) |
| PL (1) | PL2420491T3 (es) |
| PT (1) | PT2420491E (es) |
| TW (1) | TW200738698A (es) |
| WO (1) | WO2007077005A1 (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0514203D0 (en) * | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
| EP2420491B1 (en) | 2005-12-30 | 2013-07-03 | Novartis AG | 3 , 5-substitued piperidine compounds as renin inhibitors |
| ES2729424T3 (es) | 2006-09-20 | 2019-11-04 | Aerie Pharmaceuticals Inc | Inhibidores de Rho cinasa |
| US8455513B2 (en) | 2007-01-10 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-aminoisoquinoline compounds |
| US8129538B1 (en) | 2007-03-28 | 2012-03-06 | Takeda Pharmaceutical Company Limited | Renin inhibitors |
| SG182223A1 (en) * | 2007-06-25 | 2012-07-30 | Novartis Ag | N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors |
| EP2202228B1 (en) | 2007-10-15 | 2014-12-10 | Takeda Pharmaceutical Company Limited | Amide compounds and use of the same |
| RU2010129690A (ru) | 2007-12-19 | 2012-01-27 | Дайниппон Сумитомо Фарма Ко., Лтд. (Jp) | Бициклические гетероциклические производные |
| NZ589019A (en) | 2008-05-05 | 2012-10-26 | Merck Frosst Canada Ltd | 3, 4 - substituted piperidine derivatives as renin inhibitors |
| CN102123990B (zh) * | 2008-06-19 | 2014-07-09 | 武田药品工业株式会社 | 杂环化合物及其用途 |
| US8450344B2 (en) | 2008-07-25 | 2013-05-28 | Aerie Pharmaceuticals, Inc. | Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| EP2421828A2 (en) * | 2009-04-24 | 2012-02-29 | Cadila Healthcare Limited | Piperidine derivatives as inhibitors of renin |
| CA2760562C (en) | 2009-05-01 | 2016-07-19 | Aerie Pharmaceuticals, Inc. | Dual mechanism inhibitors for the treatment of disease |
| CN102482256B (zh) | 2009-06-24 | 2014-11-26 | 大日本住友制药株式会社 | N-取代的环状氨基衍生物 |
| KR20140092696A (ko) * | 2013-01-16 | 2014-07-24 | 주식회사유한양행 | 신규의 페닐에티닐 벤즈아마이드 글루코키나제 활성화제 및 그의 제조방법 |
| PT3811943T (pt) | 2013-03-15 | 2023-03-15 | Aerie Pharmaceuticals Inc | Composto para uso no tratamento de distúrbios oculares |
| EP3130581A4 (en) * | 2014-04-10 | 2017-11-22 | Takeda Pharmaceutical Company Limited | Method for producing heterocyclic compound |
| JP6832946B2 (ja) | 2015-11-17 | 2021-02-24 | アエリエ ファーマシューティカルズ インコーポレイテッド | キナーゼ阻害剤およびその中間体の調製方法 |
| US9643927B1 (en) | 2015-11-17 | 2017-05-09 | Aerie Pharmaceuticals, Inc. | Process for the preparation of kinase inhibitors and intermediates thereof |
| CN109640966A (zh) | 2016-08-31 | 2019-04-16 | 爱瑞制药公司 | 眼用组合物 |
| SG11201908179UA (en) | 2017-03-31 | 2019-10-30 | Aerie Pharmaceuticals Inc | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
| WO2020056345A1 (en) | 2018-09-14 | 2020-03-19 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
| CN119059970A (zh) * | 2024-08-30 | 2024-12-03 | 上海信诺维生物医药有限公司 | 一种btk抑制剂药物中间体的制备方法 |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW224941B (es) | 1989-11-08 | 1994-06-11 | Yamanouchi Pharma Co Ltd | |
| ATE141269T1 (de) | 1991-12-18 | 1996-08-15 | Schering Corp | Imidazolyl oder imidazolylalkyl substituiert mit einem 4- oder 5-gliedrigen stickstoff enthaltenden heterozyklischen ring |
| IL111176A0 (en) | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them |
| KR100384979B1 (ko) | 1995-09-07 | 2003-10-17 | 에프. 호프만-라 로슈 아게 | 심부전증및신부전증치료용의신규한4-(옥시알콕시페닐)-3-옥시-피페리딘 |
| CA2238081A1 (en) | 1995-11-22 | 1997-05-29 | S. Jane Desolms | Inhibitors of farnesyl-protein transferase |
| AU9206798A (en) | 1997-08-28 | 1999-03-16 | Merck & Co., Inc. | Pyrrolidine and piperidine modulators of chemokine receptor activity |
| US6429213B1 (en) | 1998-06-17 | 2002-08-06 | Bristol Myers Squibb Pharma Co | Cyclic hydroxamic acids as metalloproteinase inhibitors |
| US6274735B1 (en) | 1998-08-10 | 2001-08-14 | Hoffmann-La Roche Inc. | Process and intermediates for preparation of substituted piperidines |
| WO2000026211A1 (en) | 1998-10-30 | 2000-05-11 | Merck & Co., Inc. | Thrombin inhibitors |
| US6372764B1 (en) | 1999-03-02 | 2002-04-16 | Merck & Co., Inc. | Pyrrolidine modulators of chemokine receptor activity |
| US6303593B1 (en) | 1999-03-02 | 2001-10-16 | Merck & Co., Inc. | 3-thienyl and 3-furanyl pyrrolidine modulators of chemokine receptor activity |
| AU3386500A (en) | 1999-03-02 | 2000-09-21 | Merck & Co., Inc. | 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity |
| AU3818900A (en) | 1999-04-14 | 2000-11-02 | F. Hoffmann-La Roche Ag | Process for the preparation of substituted piperidines |
| US6376672B1 (en) | 1999-04-27 | 2002-04-23 | Hoffmann-La Roche Inc. | Naphthalenylmethoxypiperidines as renin inhibitors |
| US6197959B1 (en) | 1999-04-27 | 2001-03-06 | Hoffmann-La Roche Inc. | Piperidine derivatives |
| HUP0300850A2 (hu) | 2000-03-17 | 2003-07-28 | Bristol-Myers Squibb Pharma Company | Gyűrűs béta-aminosav-származékok mint mátrix metalloproteázok és a TNF-alfa inhibitorok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
| CA2405535A1 (en) * | 2000-04-04 | 2001-10-11 | Brandeis University | Catalytic asymmetric desymmetrization of meso compounds |
| FR2811673B1 (fr) | 2000-07-17 | 2002-09-13 | Rhodia Chimie Sa | Utilisation de composes insatures comprenant un heterocycle comme stabilisants de polymeres halogenes |
| JP2004512323A (ja) | 2000-10-11 | 2004-04-22 | メルク エンド カムパニー インコーポレーテッド | Ｃｃｒ５ケモカイン受容体活性のピロリジンモジュレーター |
| AU2002306848A1 (en) | 2001-03-23 | 2002-10-08 | Elan Pharmaceuticals, Inc. | Methods of treating alzheimer's disease with piperidin derivates |
| JP2004534017A (ja) | 2001-04-27 | 2004-11-11 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｂａｃｅのインヒビター |
| US6740649B2 (en) | 2001-09-17 | 2004-05-25 | Bristol-Myers Squibb Company | Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |
| WO2003031443A1 (en) | 2001-10-04 | 2003-04-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
| CN1649870A (zh) | 2002-04-29 | 2005-08-03 | 埃科特莱茵药品有限公司 | 7－芳基－3,9－二氮杂双环[3.3.1]壬－6－烯衍生物及其在治疗高血压,心血管或肾疾病中作为肾素抑制剂的应用 |
| AU2003301959A1 (en) | 2002-05-20 | 2004-06-03 | Bristol-Myers Squibb Company | Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| WO2004004665A2 (en) | 2002-07-09 | 2004-01-15 | Bristol-Myers Squibb Company | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| US20040214832A1 (en) | 2003-04-10 | 2004-10-28 | Cuiman Cai | Piperazine derivative renin inhibitors |
| US20040204455A1 (en) | 2003-04-10 | 2004-10-14 | Cody Wayne Livingston | Piperidine derivative rennin inhibitors |
| CA2521951A1 (en) | 2003-04-28 | 2004-11-11 | Actelion Pharmaceuticals Ltd | Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors |
| BRPI0409881A (pt) | 2003-04-29 | 2006-05-23 | Actelion Pharmaceuticals Ltd | compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos |
| JP2006524654A (ja) | 2003-04-30 | 2006-11-02 | アクテリオン ファマシューティカルズ リミテッド | 新規アザビシクロノネン誘導体 |
| JP2006524655A (ja) | 2003-04-30 | 2006-11-02 | アクテリオン ファマシューティカルズ リミテッド | ３−位にヘテロ原子を有する新規９−アザビシクロノネン誘導体 |
| WO2004096799A1 (en) | 2003-04-30 | 2004-11-11 | Actelion Pharmaceuticals Ltd | Tropane derivatives and their use as ace inhibitors |
| MXPA05011711A (es) | 2003-05-02 | 2006-01-23 | Actelion Pharmaceuticals Ltd | Derivados de diazabiciclononeno. |
| TW200900399A (en) * | 2003-10-01 | 2009-01-01 | Speedel Experimenta Ag | Organic compounds |
| AU2004283814A1 (en) | 2003-10-09 | 2005-05-06 | Actelion Pharmaceuticals Ltd. | Tetrahydropyridine derivatives |
| CN102260188A (zh) | 2003-11-26 | 2011-11-30 | 诺瓦提斯公司 | 有机化合物 |
| ES2332053T3 (es) * | 2003-11-26 | 2010-01-25 | Novartis Ag | Derivados 4-fenilpiperidina como inhibidores de renina. |
| PT1735270E (pt) | 2004-01-23 | 2010-08-27 | Novartis Ag | Diamino-álcoois e sua utilização como inibidores da renina |
| PT1756037E (pt) | 2004-01-23 | 2011-02-25 | Novartis Ag | Derivados de aminoálcoois e a sua actividade como inibidores de renina |
| EP1711456A2 (en) | 2004-01-23 | 2006-10-18 | Speedel Experimenta AG | Amino alcohol derivatives and their use as renin inhibitors |
| WO2005090305A1 (en) | 2004-03-19 | 2005-09-29 | Speedel Experimenta Ag | 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension |
| US7868036B2 (en) | 2004-03-19 | 2011-01-11 | Novartis Ag | Organic compounds |
| TW200613274A (en) | 2004-07-09 | 2006-05-01 | Speedel Experimenta Ag | Organic compounds |
| TW200631929A (en) | 2004-12-10 | 2006-09-16 | Speedel Experimenta Ag | ω -phenyloctanamides |
| GB0428250D0 (en) | 2004-12-23 | 2005-01-26 | Novartis Ag | Organic compounds |
| GB0428526D0 (en) | 2004-12-30 | 2005-02-09 | Novartis Ag | Organic compounds |
| GB0500784D0 (en) | 2005-01-14 | 2005-02-23 | Novartis Ag | Organic compounds |
| GB0504850D0 (en) | 2005-03-09 | 2005-04-13 | Novartis Ag | Organic compounds |
| US20080176947A1 (en) | 2005-03-11 | 2008-07-24 | Peter Herold | Heterocyclic-Substituted Alkanamides Useful as Renin Inhibitors |
| GB0505969D0 (en) | 2005-03-23 | 2005-04-27 | Novartis Ag | Organic compounds |
| AR053836A1 (es) | 2005-03-31 | 2007-05-23 | Speedel Experimenta Ag | Piperdinas 3,4,5-sustituidas |
| TW200722424A (en) | 2005-03-31 | 2007-06-16 | Speedel Experimenta Ag | Substituted piperidines |
| GB0508992D0 (en) | 2005-05-03 | 2005-06-08 | Novartis Ag | Organic compounds |
| GB0510810D0 (en) | 2005-05-26 | 2005-06-29 | Novartis Ag | Organic compounds |
| GB0511063D0 (en) | 2005-05-31 | 2005-07-06 | Novartis Ag | Organic compounds |
| GB0514203D0 (en) | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
| ATE469643T1 (de) | 2005-09-17 | 2010-06-15 | Novartis Ag | Mit gesättigten o-heterocyclen substituierte alkansäureamide |
| ES2328630T3 (es) | 2005-09-17 | 2009-11-16 | Novartis Ag | Derivados de 5-amino-4-hydroxi-7-(imidazo (1,2-a>)piridin-6- ilmetil-8-metil-nonamida y compuestos relacionados como inhibidores de la renina para el tratamiento de la hipertension. |
| PE20071079A1 (es) | 2005-11-15 | 2007-12-16 | Cytokinetics Inc | Compuestos de piperidina como inhibidores de la proliferacion celular |
| EP2420491B1 (en) | 2005-12-30 | 2013-07-03 | Novartis AG | 3 , 5-substitued piperidine compounds as renin inhibitors |
| EP1816122A3 (en) | 2006-01-19 | 2007-09-19 | Speedel Experimenta AG | 3,4,5-substituted piperidines as therapeutic compounds |
| CA2641120A1 (en) | 2006-01-30 | 2007-08-02 | Speedel Experimenta Ag | Process for the stereoselective preparation of alcohols from alpha, beta- insaturated compounds |
| TW200815425A (en) | 2006-06-08 | 2008-04-01 | Speedel Experimenta Ag | 2,5-disubstituted piperidines |
| GB0611697D0 (en) | 2006-06-13 | 2006-07-26 | Novartis Ag | Organic compounds |
| GB0611696D0 (en) | 2006-06-13 | 2006-07-26 | Novartis Ag | Organic compounds |
| EP1908471A1 (en) | 2006-10-04 | 2008-04-09 | Speedel Experimenta AG | Tetrahydropyridines as renin inhibitors |
-
2006
- 2006-12-28 EP EP11185536.7A patent/EP2420491B1/en active Active
- 2006-12-28 PE PE2006001709A patent/PE20071177A1/es not_active Application Discontinuation
- 2006-12-28 BR BRPI0620736-7A patent/BRPI0620736A2/pt not_active IP Right Cessation
- 2006-12-28 AU AU2006332124A patent/AU2006332124B2/en not_active Ceased
- 2006-12-28 ES ES11185536T patent/ES2430139T3/es active Active
- 2006-12-28 EP EP06829892.6A patent/EP1968940B1/en not_active Revoked
- 2006-12-28 CA CA2633624A patent/CA2633624C/en not_active Expired - Fee Related
- 2006-12-28 PE PE2010000928A patent/PE20110117A1/es not_active Application Discontinuation
- 2006-12-28 JP JP2008547900A patent/JP5306821B2/ja not_active Expired - Fee Related
- 2006-12-28 AR ARP060105852A patent/AR058885A1/es not_active Application Discontinuation
- 2006-12-28 KR KR1020087018705A patent/KR20080086921A/ko not_active Abandoned
- 2006-12-28 PT PT111855367T patent/PT2420491E/pt unknown
- 2006-12-28 PL PL11185536T patent/PL2420491T3/pl unknown
- 2006-12-28 WO PCT/EP2006/012581 patent/WO2007077005A1/en not_active Ceased
- 2006-12-28 US US12/159,749 patent/US8129411B2/en not_active Expired - Fee Related
- 2006-12-28 ES ES06829892.6T patent/ES2476422T3/es active Active
- 2006-12-28 NZ NZ569135A patent/NZ569135A/en not_active IP Right Cessation
- 2006-12-29 TW TW095149881A patent/TW200738698A/zh unknown
-
2008
- 2008-06-10 IL IL192024A patent/IL192024A0/en unknown
- 2008-06-19 MA MA31057A patent/MA30073B1/fr unknown
- 2008-06-19 CR CR10091A patent/CR10091A/es not_active Application Discontinuation
- 2008-06-27 EC EC2008008587A patent/ECSP088587A/es unknown
- 2008-07-25 NO NO20083315A patent/NO20083315L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP5306821B2 (ja) | 2013-10-02 |
| KR20080086921A (ko) | 2008-09-26 |
| AU2006332124A1 (en) | 2007-07-12 |
| PE20071177A1 (es) | 2008-01-18 |
| PT2420491E (pt) | 2013-10-14 |
| BRPI0620736A2 (pt) | 2011-12-20 |
| IL192024A0 (en) | 2008-12-29 |
| EP1968940B1 (en) | 2014-04-02 |
| ECSP088587A (es) | 2008-07-30 |
| JP2009522226A (ja) | 2009-06-11 |
| AR058885A1 (es) | 2008-02-27 |
| EP2420491B1 (en) | 2013-07-03 |
| MA30073B1 (fr) | 2008-12-01 |
| PL2420491T3 (pl) | 2013-12-31 |
| CR10091A (es) | 2008-10-27 |
| WO2007077005A1 (en) | 2007-07-12 |
| CA2633624C (en) | 2013-11-19 |
| EP1968940A1 (en) | 2008-09-17 |
| PE20110117A1 (es) | 2011-03-07 |
| ES2430139T3 (es) | 2013-11-19 |
| EP2420491A1 (en) | 2012-02-22 |
| US8129411B2 (en) | 2012-03-06 |
| TW200738698A (en) | 2007-10-16 |
| ES2476422T3 (es) | 2014-07-14 |
| AU2006332124B2 (en) | 2011-03-03 |
| NZ569135A (en) | 2011-08-26 |
| CA2633624A1 (en) | 2007-07-12 |
| US20090192148A1 (en) | 2009-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20083315L (no) | 3,5-substituert piperidin-bestanddeler som renin-inhibitorer | |
| NO20075365L (no) | 3,4-substituerte pyrrolidinderivater for behandling av hypertensjon | |
| TW200635915A (en) | Organic compounds | |
| NO20080914L (no) | Mellomprodukt for syntetisering av farmasoytisk middel og fremgangsmate for fremstilling av dette | |
| NO20091620L (no) | Boronsyre og estere som inhibitorer av fettsyreamidhydrolaser | |
| NO20070199L (no) | Substituerte kinazoloner som anti-kreftmidler | |
| NO20070566L (no) | Azin-karboksamider som antikreftmiddel | |
| NO20073719L (no) | Kjemiske forbindelser | |
| MX2007005644A (es) | Pirazolo-pirimidinas 1,4-sustituidas como inhibidores de cinasa. | |
| NO20091683L (no) | Kjemiske forbindelser | |
| NO20072784L (no) | Pyridenkarboksamidderivater for anvendelse som anticancer midler | |
| NO20084202L (no) | 4-anilinoquinolin-3-carboksamider som CSF-1R kinase inhibitorer | |
| UA113186C2 (xx) | Макроциклічні інгібітори lrrk2 кінази | |
| NO20054769L (no) | Substituerte fenylalkansyrer | |
| BRPI0519443A2 (pt) | composto orgÂnicos | |
| MX2007011009A (es) | Compuestos de piperidina 3,4,5-substituidos. | |
| NO20081681L (no) | N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika | |
| WO2006125621A8 (en) | Substituted piperidines as renin inhibitors | |
| NO20082690L (no) | Kjemiske forbindelser | |
| BG108941A (en) | Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic | |
| WO2007006534A3 (en) | Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity | |
| HUE032235T2 (en) | Azetidinyloxyphenylpyrrolidone compounds | |
| WO2006074924A8 (en) | 3,4,(5)-substituted tetrahvdropyridines | |
| NO20064344L (no) | Caspaseinhibitorer og anvendelser derav | |
| NO20073156L (no) | Stabilisering av radiofarmasoytiske forlopere |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |